Pyridyl‐Imidazopyridine Derivatives Displaying Submicromolar Activity Against Trypanosoma cruzi
ChemMedChem · 14.07.2026 · 21 (13)
DOI: 10.1002/cmdc.70377 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemMedChem, online erschienen am 10.07.2026. Verfasst von Ana Carolina Rocha Barreto und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Pontifical Catholic University of Rio de Janeiro, Rio de Janeiro, Rio de Janeiro, Brazil. Hauptthemen laut MEDLINE: Trypanosoma cruzi, Pyridines, Trypanocidal Agents, Imidazoles. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Fundação de Amparo à Pesquisa do Estado de São Paulo.
Abstract (Originalsprache)
Chagas disease, caused by the protozoan Trypanosoma cruzi (T. cruzi) , remains a major public health challenge due to the limited efficacy and high toxicity of current treatments. In this study, we describe the design and synthesis of 10 imidazo[1,2‐a]pyridine derivatives as potential antitrypanosomal agents. All compounds were evaluated in vitro against intracellular forms of T. cruzi , and the most active were further assessed for cytotoxicity and cruzain inhibition. Molecular docking studies were also conducted to investigate their binding modes in the enzyme active site. Some pyridyl‐substituted derivatives showed high potency, with submicromolar EC 50 values. Among them, compound 5h emerged as the most promising, with an EC 50 of 0.16 μM, a selectivity index greater than 1250, and an IC 50 of 10.6 μM against cruzain. Docking studies highlighted the importance of Cys25, Leu67, Met68, Ala133, and Glu205 in ligand recognition and suggested that chlorine substitution and pyridyl orientation influence cruzain binding. However, the discrepancy between the high cellular activity and the moderate cruzain inhibition, together with the weak inhibition observed for other active derivatives, suggests a likely multitarget mechanism of action. Overall, these findings highlight pyridyl‐imidazopyridines as promising scaffolds for the development of new anti‐ T. cruzi agents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Pontifical Catholic University of Rio de Janeiro, Rio de Janeiro, Rio de Janeiro, Brazil.
- Cell Biology Laboratory, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Rio de Janeiro, Brazil.
- Interdisciplinary Center for Biochemical Research, University of Mogi das Cruzes, Mogi das Cruzes, Brazil.
Förderung
- Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Fundação de Amparo à Pesquisa do Estado de São Paulo
Zitieren
APA
Barreto, A. C. R., Figueira, K. L., Azevedo, R., Conceição, K. D., Fiuza, L. F. A., Vianna, L. D. S., Moraes, T. A., Júdice, W. A. S., Soeiro, M. N. C., & Limberger, J. (2026). Pyridyl‐Imidazopyridine Derivatives Displaying Submicromolar Activity Against Trypanosoma cruzi. ChemMedChem, 21(13). https://doi.org/10.1002/cmdc.70377
Vancouver
Barreto ACR, Figueira KL, Azevedo R, Conceição KD, Fiuza LFA, Vianna LDS, et al. Pyridyl‐Imidazopyridine Derivatives Displaying Submicromolar Activity Against Trypanosoma cruzi. ChemMedChem. 2026;21(13). doi:10.1002/cmdc.70377
BibTeX
@article{Barreto2026,
author = {Barreto, Ana Carolina Rocha and Figueira, Kelly Lopes and Azevedo, Raquel and Conceição, Ketlym da and Fiuza, Ludmila de Ferreira de Almeida and Vianna, Luan Dos Santos and Moraes, Thiago Apolinário de and Júdice, Wagner Alves de Souza and Soeiro, Maria de Nazaré Correia and Limberger, Jones},
title = {Pyridyl‐Imidazopyridine Derivatives Displaying Submicromolar Activity Against Trypanosoma cruzi},
journal = {ChemMedChem},
year = {2026},
volume = {21},
number = {13},
doi = {10.1002/cmdc.70377}
}
EUVIMED